Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-302.36M
↓ 138% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-127.05M
Historical baseline
PeriodValueYoY Change
TTM$-302.36M-39.8%
2024$-216.24M-51.0%
2023$-143.20M+5.6%
2022$-151.66M-55.3%
2021$-97.64M-123.4%
2020$-43.72M-8.3%
2019$-40.38M-90.0%
2018$-21.25M-